You are here

Eli Lilly

Companies to Watch: 12 Late-Stage Contenders in Neurodegenerative Disease

BioSpace

Mon, 07/24/23 - 09:57 am

neurodegenerative disease

Alzheimer's disease

Axsome Therapeutics

BrainStorm Cell Therapeutics

Seelos Therapeutics

Parkinson's Disease

Mitsubishi Tanabe Pharma

Huntington's disease

Prilenia Therapeutics

Novo Nordisk, Eli Lilly and Boehringer Ingelheim back bill to bring obesity drug coverage to Medicare

Fierce Pharma

Thu, 07/20/23 - 09:42 pm

Boehringer Ingelheim

Lilly’s donanemab flaunts strong clinical profile, ready to compete with Leqembi

Clinical Trials Arena

Wed, 07/19/23 - 10:27 am

Alzheimer's disease

Eli Lilly partners with Team U.S.A. through 2028 Olympic Games in Los Angeles

Medical Marketing and Media

Mon, 07/17/23 - 06:52 pm

pharma marketing

Lilly shares full pivotal data on Alzheimer’s drug, revealing how it shapes up against Leqembi

Fierce Biotech

Mon, 07/17/23 - 06:51 pm

Alzheimer's disease

clinical trials

AbbVie, Lilly-backed Capsida cuts staff months after signing Big Pharma deals

Fierce Biotech

Sun, 07/16/23 - 02:37 pm

Capsida Biotherapeutics

Hungry for more, Lilly tops off weight loss pipeline with $1.9B deal to acquire Versanis

Fierce Biotech

Fri, 07/14/23 - 10:10 am

Lilly, Novo, BMS return to boost BGV's largest European biotech fund yet

Fierce Biotech

Thu, 07/13/23 - 10:15 am

Bristol Myers Squibb

venture capital

After First Approval, Experts Point to Barriers in Cell Therapy for Type 1 Diabetes

BioSpace

Thu, 07/13/23 - 10:11 am

type 1 diabetes

Siglion Therapeutics

Pharma finds a way to gain weight

EP Vantage

Thu, 07/13/23 - 09:49 am

Biopharma’s green shoots thriving in summer sun as deal activity returns

Fierce Biotech

Tue, 07/11/23 - 11:18 pm

Siglion Therapeutics

DiCE Therapeutics

Biopharma buyouts bounce back

EP Vantage

Wed, 07/5/23 - 10:17 am

Horizon Therapeutics

Pfizer Just Canned One of Its Ozempic Killers. What's Next?

Motley Fool

Mon, 07/3/23 - 10:37 am

Lilly to Buy European ADC Player Emergence Therapeutics

BioSpace

Fri, 06/30/23 - 10:20 am

Emergence Therapeutics

antibody-drug conjugate

Eli Lilly to buy Sigilon Therapeutics to expand diabetes treatments

Yahoo/Reuters

Thu, 06/29/23 - 11:56 am

ADA 2023 – Lilly unveils its triple threat

EP Vantage

Wed, 06/28/23 - 09:57 am

clinical trials

Lilly forks over $2.4M to settle federal agency's age discrimination lawsuit

Fierce Pharma

Tue, 06/27/23 - 10:39 pm

age discrimination

Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle

Fierce Biotech

Mon, 06/26/23 - 10:00 am

Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event?

Motley Fool

Wed, 06/21/23 - 11:02 pm

DiCE Therapeutics

ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer

EP Vantage

Wed, 06/21/23 - 10:38 am

Pages